In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists.
Bettina A. Hamelin, Jacques Turgeon(Unknown), Benoît Drolet(Hôpital du Saint-Sacrement), Annie Gravel, A. Bouayad
PubMed
June 1, 1998
Cited by 80
Related Papers
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
|Pharmaceutics|2020|237
Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
|Annals of Pharmacotherapy|2013|186
Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
|PubMed|1999|177